Murielle ROUSSEL, MD

Trials

Studies that name Murielle ROUSSEL, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:01 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06649695 · A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

  European Myeloma Network B.V. · active not recruiting · AL Amyloidosis · principal investigator
• Ph2
  NCT02897830 · Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma

  University Hospital, Toulouse · terminated · Multiple Myeloma · principal investigator
• Ph2
  NCT02405364 · Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

  University Hospital, Toulouse · completed · Multiple Myeloma · principal investigator
• Ph3
  NCT02197221 · Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma

  University Hospital, Toulouse · completed · Multiple Myeloma · principal investigator
• Ph2
  NCT00642395 · Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)

  University Hospital, Toulouse · completed · Multiple Myeloma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.